Research
Source of News
World Health Organization
Two new candidate vaccines to join Ebola trial as treatment research advances
WHO adds two Bundibugyo-specific vaccine candidates to ongoing trial
WHO expert groups recommend adding two vaccine candidates specifically developed for Bundibugyo virus to ongoing trials: ChAdOx1 BDBV (Oxford/Serum Institute) and Moderna's mRNA-1469. The trial is led by DRC's National Institute for Biomedical Research.
Why this matters
New Bundibugyo-specific vaccines are entering trials; if you are in a high-risk area or a healthcare worker, stay informed about vaccine availability and eligibility.